世界の市販OTC鎮痛薬市場2020-2024

◆英語タイトル:Global Over the Counter (OTC) Analgesics Market 2020-2024
◆商品コード:IRTNTR43442
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年5月4日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥312,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥416,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは市販OTC鎮痛薬の世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、種類別(内服用、外用)分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・市販OTC鎮痛薬の世界市場:種類別(内服用、外用)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Over The Counter (OTC) Analgesics Market 2020-2024

Technavio has been monitoring the over the counter (OTC) analgesics market and it is poised to grow by $ 5.85 bn during 2020-2024 progressing at a CAGR of 6% during the forecast period. Our reports on over the counter (OTC) analgesics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of pain-related conditions and growing number of launches of OTC analgesics. In addition, increasing prevalence of pain-related conditions is anticipated to boost the growth of the market as well.

The over the counter (OTC) analgesics market analysis includes type segment and geographic landscapes
Technavio’s over the counter (OTC) analgesics market is segmented as below:
By Type
• Internal OTC analgesics
• external OTC analgesics

By Geographic Landscapes
• North America
• Europe
• Asia
• ROW

This study identifies growing number of merger and acquisition (M&A) activities as one of the prime reasons driving the over the counter (OTC) analgesics market growth during the next few years.
“Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our over the counter (OTC) analgesics market covers the following areas:
• Over the counter (OTC) analgesics market sizing
• Over the counter (OTC) analgesics market forecast
• Over the counter (OTC) analgesics market industry analysis”

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading over the counter (OTC) analgesics market vendors that include Bayer AG, Cipla Inc., GlaxoSmithKline Plc, Johnson & Johnson, Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group Plc, Sanofi, and Sun Pharmaceutical Industries Ltd.. Also, the over the counter (OTC) analgesics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/global-over-the-counter-otc-analgesics-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Type
o Market segments
o Comparison by Type
o Internal – Market size and forecast 2019-2024
o External – Market size and forecast 2019-2024
o Market opportunity by Type
• Customer Landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Volume driver – Demand led growth
o Volume driver – Supply led growth
o Volume driver – External factors
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Bayer AG
o Cipla Inc.
o GlaxoSmithKline Plc
o Johnson & Johnson
o Perrigo Co. Plc
o Pfizer Inc.
o Piramal Enterprises Ltd.
o Reckitt Benckiser Group Plc
o Sanofi
o Sun Pharmaceutical Industries Ltd.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ billion)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Type – Market share 2019-2024 (%)
• 22: Comparison by Type
• 23: Internal – Market size and forecast 2019-2024 ($ billion)
• 24: Internal – Year-over-year growth 2019-2024 (%)
• 25: External – Market size and forecast 2019-2024 ($ billion)
• 26: External – Year-over-year growth 2019-2024 (%)
• 27: Market opportunity by Type
• 28: Customer landscape
• 29: Market share by geography 2019-2024 (%)
• 30: Geographic comparison
• 31: North America – Market size and forecast 2019-2024 ($ billion)
• 32: North America – Year-over-year growth 2019-2024 (%)
• 33: Asia – Market size and forecast 2019-2024 ($ billion)
• 34: Asia – Year-over-year growth 2019-2024 (%)
• 35: Europe – Market size and forecast 2019-2024 ($ billion)
• 36: Europe – Year-over-year growth 2019-2024 (%)
• 37: ROW – Market size and forecast 2019-2024 ($ billion)
• 38: ROW – Year-over-year growth 2019-2024 (%)
• 39: Key leading countries
• 40: Market opportunity by geography ($ billion)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: Bayer AG – Overview
• 48: Bayer AG – Business segments
• 49: Bayer AG – Key offerings
• 50: Bayer AG – Key customers
• 51: Bayer AG – Segment focus
• 52: Cipla Inc. – Overview
• 53: Cipla Inc. – Business segments
• 54: Cipla Inc. – Key offerings
• 55: Cipla Inc. – Key customers
• 56: Cipla Inc. – Segment focus
• 57: GlaxoSmithKline Plc – Overview
• 58: GlaxoSmithKline Plc – Business segments
• 59: GlaxoSmithKline Plc – Key offerings
• 60: GlaxoSmithKline Plc – Key customers
• 61: GlaxoSmithKline Plc – Segment focus
• 62: Johnson & Johnson – Overview
• 63: Johnson & Johnson – Business segments
• 64: Johnson & Johnson – Key offerings
• 65: Johnson & Johnson – Key customers
• 66: Johnson & Johnson – Segment focus
• 67: Perrigo Co. Plc – Overview
• 68: Perrigo Co. Plc – Business segments
• 69: Perrigo Co. Plc – Key offerings
• 70: Perrigo Co. Plc – Key customers
• 71: Perrigo Co. Plc – Segment focus
• 72: Pfizer Inc. – Overview
• 73: Pfizer Inc. – Business segments
• 74: Pfizer Inc. – Key offerings
• 75: Pfizer Inc. – Key customers
• 76: Pfizer Inc. – Segment focus
• 77: Piramal Enterprises Ltd. – Overview
• 78: Piramal Enterprises Ltd. – Business segments
• 79: Piramal Enterprises Ltd. – Key offerings
• 80: Piramal Enterprises Ltd. – Key customers
• 81: Piramal Enterprises Ltd. – Segment focus
• 82: Reckitt Benckiser Group Plc – Overview
• 83: Reckitt Benckiser Group Plc – Business segments
• 84: Reckitt Benckiser Group Plc – Key offerings
• 85: Reckitt Benckiser Group Plc – Key customers
• 86: Reckitt Benckiser Group Plc – Segment focus
• 87: Sanofi – Overview
• 88: Sanofi – Business segments
• 89: Sanofi – Key offerings
• 90: Sanofi – Key customers
• 91: Sanofi – Segment focus
• 92: Sun Pharmaceutical Industries Ltd. – Overview
• 93: Sun Pharmaceutical Industries Ltd. – Business segments
• 94: Sun Pharmaceutical Industries Ltd. – Key offerings
• 95: Sun Pharmaceutical Industries Ltd. – Key customers
• 96: Sun Pharmaceutical Industries Ltd. – Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations



【掲載企業】

Bayer AG, Cipla Inc., GlaxoSmithKline Plc, Johnson & Johnson, Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group Plc, Sanofi, Sun Pharmaceutical Industries Ltd.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の市販OTC鎮痛薬市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆